Earnings summaries and quarterly performance for HEALTHPEAK PROPERTIES.
Executive leadership at HEALTHPEAK PROPERTIES.
Scott M. Brinker
Detailed
President and Chief Executive Officer
CEO
AG
Adam G. Mabry
Detailed
Chief Investment Officer
AB
Ankit B. Patadia
Detailed
Executive Vice President and Treasurer – Corporate Finance
KO
Kelvin O. Moses
Detailed
Chief Financial Officer
LA
Lisa A. Alonso
Detailed
Executive Vice President and Chief Human Resources Officer
SR
Scott R. Bohn
Detailed
Chief Development Officer and Head of Lab
SG
Shawn G. Johnston
Detailed
Executive Vice President and Chief Accounting Officer
TA
Tracy A. Porter
Detailed
Executive Vice President and General Counsel
Board of directors at HEALTHPEAK PROPERTIES.
AE
Ava E. Lias-Booker
Detailed
Independent Director
BG
Brian G. Cartwright
Detailed
Independent Director
GT
Governor Tommy G. Thompson
Detailed
Independent Director
JB
James B. Connor
Detailed
Independent Director
JT
John T. Thomas
Detailed
Vice Chair of the Board
KM
Katherine M. Sandstrom
Detailed
Independent Chair of the Board
PJ
Pamela J. Kessler
Detailed
Independent Director
RK
R. Kent Griffin, Jr.
Detailed
Independent Director
RA
Richard A. Weiss
Detailed
Independent Director
SG
Sara G. Lewis
Detailed
Independent Director
Research analysts who have asked questions during HEALTHPEAK PROPERTIES earnings calls.
AW
Austin Wurschmidt
KeyBanc Capital Markets Inc.
4 questions for DOC
Also covers: AHR, AIV, AMH +20 more
FG
Farrell Granath
Bank of America
4 questions for DOC
Also covers: ADC, AHR, ARE +13 more
Juan Sanabria
BMO Capital Markets
4 questions for DOC
Also covers: AMH, BRX, CTRE +20 more
MC
Michael Carroll
RBC Capital Markets
4 questions for DOC
Also covers: AHR, ARE, COLD +16 more
Michael Stroyeck
Green Street Advisors, LLC
4 questions for DOC
Also covers: AHR, OHI, SBRA +1 more
RK
Ronald Kamdem
Morgan Stanley
4 questions for DOC
Also covers: AAT, ADC, AHR +37 more
VM
Vikram Malhotra
Mizuho Financial Group, Inc.
4 questions for DOC
Also covers: ALX, ARE, BXP +17 more
WG
Wesley Golladay
Robert W. Baird & Co.
4 questions for DOC
Also covers: ADC, AHR, ARE +23 more
Jamie Feldman
Wells Fargo & Company
2 questions for DOC
Also covers: AMH, ARE, AVB +17 more
John Pawlowski
Green Street
2 questions for DOC
Also covers: AIV, AMH, AVB +13 more
Jon Petersen
Jefferies
2 questions for DOC
Also covers: CORZ, CUBE, DLR +11 more
MM
Michael Mueller
JPMorgan Chase & Co.
2 questions for DOC
Also covers: AKR, BRX, CBL +26 more
MM
Mike Mueller
JPMorgan Chase & Co.
2 questions for DOC
Also covers: CURB, EXR, IVT +7 more
Nicholas Yulico
Scotiabank
2 questions for DOC
Also covers: AHR, ALX, AVB +20 more
Nick Joseph
Citigroup Inc.
2 questions for DOC
Also covers: ADC, AIV, ARE +12 more
Nick Yulico
Scotiabank
2 questions for DOC
Also covers: ALX, CPT, KRC +2 more
OO
Omotayo Okusanya
Deutsche Bank AG
2 questions for DOC
Also covers: AMH, ARE, BDN +40 more
RA
Richard Anderson
Wedbush Securities
2 questions for DOC
Also covers: AIV, ARE, AVB +25 more
Seth Bergey
Citi
2 questions for DOC
Also covers: AHR, BDN, BXP +16 more
Recent press releases and 8-K filings for DOC.
Healthpeak Properties Reports Q4 and Full Year 2025 Results, Provides 2026 Guidance, and Details Strategic Transactions
DOC
Earnings
Guidance Update
M&A
- Healthpeak Properties reported Q4 2025 FFO as adjusted of $0.47 per share and full-year FFO as adjusted of $1.84 per share, with total portfolio same-store cash NOI growth of 3.9% for Q4 and 4% for the full year.
- For 2026, the company forecasts FFO as adjusted to range from $1.70-$1.74 per share and total same-store NOI growth between -1% and +1%.
- Strategic activities include the sale of $325 million in Outpatient Medical assets in Q4 2025, the acquisition of a 1.4 million sq ft campus in South San Francisco, and plans to contribute its Senior Housing portfolio to Janus Living for a planned IPO.
- The company completed $464 million of acquisitions in early 2026, including a $314 million buyout of a joint venture partner in its Senior Housing rental portfolio, and plans $1 billion or more in asset sales, recapitalizations, and loan repayments in 2026.
- The Lab segment ended 2025 with 1.5% same-store growth and 77% total occupancy, with the operating environment showing early signs of an inflection point due to improved capital raising and M&A in the last five months of 2025.
12 hours ago
Healthpeak Properties Reports Q4 2025 Results and Provides 2026 Outlook
DOC
Earnings
Guidance Update
M&A
- Healthpeak Properties reported Q4 2025 FFO as adjusted of $0.47 per share and full-year FFO as adjusted of $1.84 per share, with total portfolio same-store cash NOI growth of 3.9% for Q4 and 4% for the full year.
- For 2026, the company forecasts FFO as adjusted to range from $1.70 to $1.74 per share and total same-store NOI growth between -1% to +1%, primarily attributing the earnings reduction to the lagging impact of occupancy loss in the lab segment.
- The outpatient medical segment delivered strong 2025 results with 4.9 million sq ft of leasing and 3.9% same-store growth, while the senior housing segment achieved 12.6% same-store growth.
- Healthpeak is preparing for the IPO of Janus Living in the first half of 2026, which will encompass all senior housing assets, and completed the Gateway acquisition to enhance its lab portfolio in South San Francisco. The company expects 2026 to be a bottom for FFO.
12 hours ago
Healthpeak Reports Q4 and Full-Year 2025 Results, Provides 2026 Guidance, and Announces Senior Housing REIT IPO
DOC
Earnings
Guidance Update
M&A
- Healthpeak reported Q4 2025 FFO as adjusted of $0.47 per share and full-year FFO as adjusted of $1.84 per share, with total portfolio same-store cash NOI growth of 3.9% in Q4 and 4% for the full year.
- For 2026, the company forecasts FFO as adjusted between $1.70 and $1.74 per share and total same-store NOI growth of -1% to +1%, with the lab segment NOI expected to decline by -5% to -10% due to lagging occupancy impacts.
- Healthpeak plans to create Janus Living, a pure-play senior housing REIT, by contributing its entire senior housing portfolio, with an IPO anticipated in the first half of 2026.
- The company strategically sold $325 million in outpatient assets in Q4 2025 and acquired the 1.4 million sq ft Gateway campus in South San Francisco in late 2025/early 2026, which has over 500,000 sq ft of vacancy.
13 hours ago
Healthpeak Properties Reports Q4 2025 Results, Provides 2026 Guidance, and Strategic Update
DOC
Earnings
Guidance Update
M&A
- Healthpeak Properties reported Net income of $0.16 per share and Nareit FFO of $0.47 per share for Q4 2025, with Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of +3.9%. For the full year 2025, Net income was $0.10 per share and Nareit FFO was $1.81 per share.
- The company issued 2026 guidance, projecting diluted earnings per common share between $0.34 and $0.38 and diluted Nareit FFO per share between $1.70 and $1.74.
- Healthpeak announced the formation and planned initial public offering (IPO) of Janus Living, Inc., a REIT focused on senior housing, anticipated in H1 2026. The company also plans $1 billion in asset sales, recapitalizations, and loan repayments in 2026 as part of its capital recycling strategy.
- The Board of Directors declared a monthly common stock cash dividend of $0.10167 per share for January, February, and March of 2026, totaling $0.305 per share for the first quarter.
1 day ago
Healthpeak Properties Reports Q4 and Full Year 2025 Results, Announces Strategic Initiatives and 2026 Guidance
DOC
Earnings
Guidance Update
M&A
- Healthpeak Properties reported Q4 2025 Net income of $0.16 per share and Nareit FFO of $0.47 per share, with Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of +3.9%. For the full year 2025, Net income was $0.10 per share and Nareit FFO was $1.81 per share, with Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of +4.0%.
- The company announced the formation and planned initial public offering (IPO) of Janus Living, Inc., a REIT dedicated to senior housing, expected in the first half of 2026 to unlock value.
- Strategic capital recycling includes $1 billion of asset sales, recapitalizations, and loan repayments targeted for 2026 , following $511 million in asset sales and loan repayments in 2025. Recent transactions include the acquisition of a 1.4 million square foot campus in South San Francisco for $600 million and $325 million in outpatient medical dispositions in Q4 2025.
- Healthpeak declared a monthly common stock cash dividend of $0.10167 per share for Q1 2026, representing an annualized dividend of $1.22 per share.
- For full year 2026, guidance includes Diluted earnings per common share from $0.34 – $0.38 and Diluted Nareit FFO per share of $1.70 – $1.74, with Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of (1%) – 1%.
1 day ago
Healthpeak Properties Announces $925 Million in Transaction Activity
DOC
M&A
New Projects/Investments
- Healthpeak Properties announced $925 million in recent transaction activity, including the $600 million acquisition of a 1.4-million square foot campus in South San Francisco and $325 million in outpatient medical dispositions during Q4 2025.
- The acquired South San Francisco campus, closed in December 2025 and January 2026, is approximately 60% occupied and expands Healthpeak's presence in the submarket to 6.5 million square feet.
- The company is pursuing additional outpatient medical sales, recapitalizations, and loan repayments that could generate $700 million or more in proceeds, supporting its strategy to reinvest into strategic life science assets.
Jan 12, 2026, 11:59 AM
Healthpeak Properties Announces Formation and IPO of Senior Housing REIT, Janus Living
DOC
New Projects/Investments
- Healthpeak Properties (DOC) announced the formation and planned initial public offering (IPO) of Janus Living, Inc., a pure-play, RIDEA-structured senior housing REIT.
- Healthpeak will contribute its 34-community, 10,422-unit senior housing portfolio to Janus Living and will retain a substantial majority interest immediately following the IPO.
- The IPO is expected to be completed in the first half of 2026, subject to market and regulatory conditions.
- Healthpeak will serve as Janus Living's external manager, receiving an annual management fee of $10 million.
- Healthpeak intends to use the net proceeds from the IPO for pending acquisitions, debt repayment, and general corporate purposes, aiming to strengthen its balance sheet.
Jan 7, 2026, 12:01 PM
Healthpeak Properties Announces Confidential IPO Submission for Janus Living
DOC
New Projects/Investments
Listing Issues
- Healthpeak Properties (DOC) has confidentially submitted a draft registration statement for the initial public offering (IPO) of Janus Living, Inc.
- Janus Living will be a newly formed company intending to elect and qualify as a real estate investment trust, focused on owning, acquiring, and developing senior housing properties under a RIDEA structure.
- The IPO will comprise 34 senior housing assets from Healthpeak, with the net proceeds expected to be used for pending acquisitions, debt repayment, and general corporate purposes.
- Healthpeak anticipates completing the IPO in the first half of 2026, subject to various conditions, and intends to maintain control of Janus Living post-offering.
Jan 7, 2026, 12:00 PM
Healthpeak Properties Reports Q3 2025 Results and Strategic Asset Recycling Plan
DOC
Earnings
Guidance Update
New Projects/Investments
- Healthpeak Properties reported FFO as adjusted of $0.46 per share and AFFO of $0.42 per share for Q3 2025, with year-to-date portfolio same-store growth at 3.8%.
- The company plans to generate $1 billion or more from outpatient medical asset sales, with $204 million already under purchase and sale agreement, intending to recycle these proceeds into higher-return lab opportunities (targeting double-digit unlevered IRRs) and outpatient development (average yield 7+%).
- Outpatient medical leasing was strong in Q3 2025, with 1.2 million square feet executed, achieving positive cash releasing spreads of 5.4% and ending the quarter with 91% occupancy.
- In the lab sector, the leasing pipeline has doubled to 1.8 million square feet since Q1 2025; however, occupancy is expected to decline to the high 70% range over the next couple of quarters before recovering, with earnings benefits starting in late 2026 and thereafter.
- The company reaffirmed its FFO as adjusted and same-store expectations within its original guidance range and reduced interest expense and G&A guidance by $10 million.
Oct 24, 2025, 2:00 PM
Healthpeak Properties Reports Q3 2025 Results and Outlines Strategic Capital Recycling
DOC
Earnings
New Projects/Investments
- Healthpeak Properties reported Q3 2025 FFO as adjusted of $0.46 per share and AFFO of $0.42 per share, with year-to-date portfolio same-store growth of 3.8%.
- The company plans to generate $1 billion or more from outpatient medical asset sales, with $130 million already under signed contract, to recycle into higher-return lab opportunities and outpatient development. This strategy is expected to create meaningful accretion.
- Leading indicators in the lab sector are positive, with the leasing pipeline doubling since the start of the year. However, lab occupancy is projected to decline to the high 70% range over the next few months before an anticipated recovery.
- Healthpeak has internalized property management on 39 million sq ft and is implementing technology initiatives to enhance operations.
Oct 24, 2025, 2:00 PM
Quarterly earnings call transcripts for HEALTHPEAK PROPERTIES.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more